Press Releases

Nationwide, consumers are demanding greener household care products, cheaper and cleaner fuels and a greater selection of biobased personal care items.  The Plenary Program and select Track Sessions at the BIO World Congress on Industrial Biotechnology, will showcase how the industrial biotech industry is meeting this growing demand for a more sustainable, environmentally friendlier lifestyle preferred by consumers.  The World Congress will be held May 12-15, 2014, at the Pennsylvania Convention Center in Philadelphia. 

Strong IP Policies and Ongoing Focus on Emerging Markets Key to Continued Innovation

The 2014 BIO International Convention® will include six timely and dynamic Super Sessions featuring prominent biotech thought leaders.  This year’s sessions will cover issues from the state of the biotech industry to transforming the world of healthcare.  

selective group of CEOs and COOs from emerging industrial biotechnology companies will present new technologies, accomplishments, and business cases during the Clean Tech Investor Sessions at the BIO World Congress on Industrial Biotechnology

As a follow-up to the March 25th dedication of the Norman E. Borlaug statue in the U.S. Capitol’s National Statuary Hall, President Obama praised the work of the Nobel Prize winner and voiced support for the promises of agricultural biotechnology.

The 2014 BIO International Convention® will highlight the role of academia in the advancement of the biotechnology field through the BIO Alliance Pavilion and the Translational Research Forum. Hosted by the Biotechnology Industry Organization (BIO), the global event for biotechnology will take place June 23-26, 2014 at the San Diego Convention Center in San Diego, California.

Registration for this year’s Livestock Biotech Summit is officially open to attendees and credentialed media, the Biotechnology Industry Organization (BIO) announced today.  The BIO Livestock Biotech Summit will be September 16-18, 2014, at the Sioux Falls Convention Center in Sioux Falls, SD. 

BIO and Delaware Bio commend the Delaware State Senate for unanimously passing legislation yesterday designed to create a pathway for the substitution of interchangeable biologic medicines. 

Consumer-focused legislation will enhance transparency and advance food safety

Washington, D.C. (April 9, 2014) – The Biotechnology Industry Organization (BIO), applauds today’s introduction of the Safe and Accurate Food Labeling Act, which would establish a federal standard for the safety and labeling of food and beverage products made with genetically modified ingredients (GMOs).

The House Subcommittee on Capital Markets and Government Sponsored Enterprises held a hearing titled “Legislative Proposals to Enhance Capital Formation for Small and Emerging Growth Companies.” Brian Hahn, Chief Financial Officer of GlycoMimetics, Inc. presented testimony at the hearing on enhancements to the capital markets that can increase access to investors and decrease unnecessary regulatory burdens for emerging biotech companies trading on the public market.

BIO Latin American Conference will bring together biotechnology executives, academics and investors from around the globe

Advances in commercial applications to be showcased at 2014 BIO World Congress in Philadelphia

The EXPIRE Act would extend tax credits that expired at the end of 2013, including several of importance to the biotechnology industry.

BIO 2014 to feature a first-time Digital Health Zone and Digital Health Forum

BIO analysis shows that waiting times for EPA approval of new biofuel production pathways under the Renewable Fuel Standard exceed 17 months on average.

The Biotechnology Industry Organization (BIO), the National Science Foundation (NSF) and the National Institutes of Health (NIH) today announced an agreement to feature Small Business Innovation Research (SBIR) funded early-stage biomedical companies in a newly-created Innovation Zone at the 2014 BIO International Convention®. The Innovation Zone companies, focused on drug discovery, diagnostics and other platform technologies, will have dedicated exhibit space and participate in BIO’s One-on-One Partnering™ system. Select companies will make presentations in the BIO Business Forum, the Convention’s business development platform.
 

If left unchanged, the Obama administration’s proposal to slash use of biofuels in 2014 would increase emissions of greenhouse gases next year, according to a new white paper from BIO.

The Biotechnology Industry Organization (BIO) and the Indiana Health Industry Forum (IHIF) commend Indiana Governor Mike Pence for signing legislation today designed to create a pathway for the substitution of interchangeable biologic medicines.

Borlaug, winner of the Nobel Peace Prize, the Congressional Gold Medal and the Presidential Medal of Freedom, led a global agricultural evolution through his research and advocacy for modern farming practices.  Known as the Father of the Green Revolution, Borlaug is credited with saving more than a billion people from starvation with the development of high-yield, disease-resistant crop varieties and modern agricultural systems.

Principles reaffirm and broaden biotech industry’s commitment to transparency, advancing research

Advanced biofuel producers will discuss the industry’s progress toward commercial reality during breakout sessions at the World Congress on Industrial Biotechnology, the Biotechnology Industry Organization announced today.  The World Congress will be held May 12-15, 2014, at the Pennsylvania Convention Center in Philadelphia.